Tablo Announces $76.5M Investment.

*Bringing its total to $185.5M, Outset Medical announces a new investment from T. Row Price Associates. The Tablo machine is rethinking HD technology from the ground up. A minifridge-sized unit can purify tap water, send and receive data, and even clear air bubbles from the dialyzer and bloodlines.

Read the full article » | Posted 06-12-2017

Related Articles

• Gel Increases Success Rate of AVF Development Posted 01-14-2022
• Alio and Lifeline Partner for Dialysis Access Patient Monitoring Posted 12-16-2021
• Patient Needs Should Drive Kidney Innovation Posted 12-16-2021
• PeritoneX Internally Disinfects PD Catheters Posted 11-12-2021